FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950133034> ?p ?o ?g. }

• W2950133034 endingPage "341" @default.
• W2950133034 startingPage "335" @default.
• W2950133034 abstract "Background The prevalence of psychiatric comorbidities in patients with chronic urticaria (CU) in a national population is largely unknown. Objectives To investigate the prevalence of psychiatric disorders and psychiatric medication use in patients with CU in Taiwan. Methods Data were sourced from Taiwan's National Health Insurance Research Database for 2011. Patients who had a primary/secondary International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code of 708·1, 708·8 or 708·9 during 2011 with at least two outpatient visits and an antihistamine prescription were identified as CU cases. Patients with CU were classified into three disease severity groups according to their medication types. Psychiatric disorders were identified by patients having three outpatient visits with a primary or secondary diagnosis of a given psychiatric disease. Psychiatric medication use was defined by having at least four outpatient visits with prescriptions for anxiolytics, antidepressants or sleeping pills in 2010 or 2011. Results Of the 167 132 patients with CU, 82·5% had mild CU, 17·0% had moderate CU and 0·4% had severe CU. Patients with CU had a higher prevalence of psychiatric disorders and psychiatric medication prescription than control groups. The relative risk (RR) of psychiatric disorders was 1·43 for patients with mild, 1·50 for patients with moderate and 2·32 for patients with severe CU vs. the controls (P < 0·001). For psychiatric medication prescription, the RRs were 1·95, 2·70 and 2·09, respectively, vs. controls (P < 0·001). Conclusions Patients with CU had a higher prevalence and risk of psychiatric disorders and psychiatric medication prescription than control groups. What's already known about this topic? Previous studies have shown a high prevalence of psychiatric comorbidities in patients with chronic urticaria (CU), with rates ranging from 35% to 60%. Anxiety, depression and somatoform disorders have been reported as the most prevalent mental disorders in patients with CU. What does this study add? Patients with CU had a higher prevalence of psychiatric disorders and psychiatric medication use than control groups in the general population. The relative risk (RR) of psychiatric disorders was 1·43 for those with mild CU, 1·50 for those with moderate CU and 2·32 for those with severe CU vs. controls. The RR for psychiatric medication use was 1·95 for those with mild CU, 2·70 for those with moderate CU and 2·09 for those with severe CU vs. controls. Mental health evaluations and management are important elements in CU management." @default.
• W2950133034 created "2019-06-27" @default.
• W2950133034 creator A5017550412 @default.
• W2950133034 creator A5023141808 @default.
• W2950133034 creator A5031223551 @default.
• W2950133034 creator A5045193605 @default.
• W2950133034 creator A5062947819 @default.
• W2950133034 creator A5073678445 @default.
• W2950133034 date "2019-09-18" @default.
• W2950133034 modified "2023-10-14" @default.
• W2950133034 title "Patients with chronic urticaria have a higher risk of psychiatric disorders: a population‐based study" @default.
• W2950133034 cites W1962722127 @default.
• W2950133034 cites W1968581880 @default.
• W2950133034 cites W2015010757 @default.
• W2950133034 cites W2027409607 @default.
• W2950133034 cites W2054805011 @default.
• W2950133034 cites W2082095662 @default.
• W2950133034 cites W2082643431 @default.
• W2950133034 cites W2083226142 @default.
• W2950133034 cites W2093029881 @default.
• W2950133034 cites W2109065974 @default.
• W2950133034 cites W2117092022 @default.
• W2950133034 cites W2118483037 @default.
• W2950133034 cites W2118904473 @default.
• W2950133034 cites W2119253961 @default.
• W2950133034 cites W2149120102 @default.
• W2950133034 cites W2172166516 @default.
• W2950133034 cites W2196453061 @default.
• W2950133034 cites W2340688634 @default.
• W2950133034 cites W2394944491 @default.
• W2950133034 cites W2734815655 @default.
• W2950133034 cites W2810953097 @default.
• W2950133034 cites W4361867206 @default.
• W2950133034 doi "https://doi.org/10.1111/bjd.18240" @default.
• W2950133034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31220338" @default.
• W2950133034 hasPublicationYear "2019" @default.
• W2950133034 type Work @default.
• W2950133034 sameAs 2950133034 @default.
• W2950133034 citedByCount "12" @default.
• W2950133034 countsByYear W29501330342020 @default.
• W2950133034 countsByYear W29501330342021 @default.
• W2950133034 countsByYear W29501330342022 @default.
• W2950133034 countsByYear W29501330342023 @default.
• W2950133034 crossrefType "journal-article" @default.
• W2950133034 hasAuthorship W2950133034A5017550412 @default.
• W2950133034 hasAuthorship W2950133034A5023141808 @default.
• W2950133034 hasAuthorship W2950133034A5031223551 @default.
• W2950133034 hasAuthorship W2950133034A5045193605 @default.
• W2950133034 hasAuthorship W2950133034A5062947819 @default.
• W2950133034 hasAuthorship W2950133034A5073678445 @default.
• W2950133034 hasConcept C118552586 @default.
• W2950133034 hasConcept C126322002 @default.
• W2950133034 hasConcept C2426938 @default.
• W2950133034 hasConcept C2908647359 @default.
• W2950133034 hasConcept C3020110884 @default.
• W2950133034 hasConcept C71924100 @default.
• W2950133034 hasConcept C81603835 @default.
• W2950133034 hasConcept C98274493 @default.
• W2950133034 hasConcept C99454951 @default.
• W2950133034 hasConceptScore W2950133034C118552586 @default.
• W2950133034 hasConceptScore W2950133034C126322002 @default.
• W2950133034 hasConceptScore W2950133034C2426938 @default.
• W2950133034 hasConceptScore W2950133034C2908647359 @default.
• W2950133034 hasConceptScore W2950133034C3020110884 @default.
• W2950133034 hasConceptScore W2950133034C71924100 @default.
• W2950133034 hasConceptScore W2950133034C81603835 @default.
• W2950133034 hasConceptScore W2950133034C98274493 @default.
• W2950133034 hasConceptScore W2950133034C99454951 @default.
• W2950133034 hasIssue "2" @default.
• W2950133034 hasLocation W29501330341 @default.
• W2950133034 hasOpenAccess W2950133034 @default.
• W2950133034 hasPrimaryLocation W29501330341 @default.
• W2950133034 hasRelatedWork W1510142055 @default.
• W2950133034 hasRelatedWork W1971206996 @default.
• W2950133034 hasRelatedWork W2062123784 @default.
• W2950133034 hasRelatedWork W2357558005 @default.
• W2950133034 hasRelatedWork W2358383113 @default.
• W2950133034 hasRelatedWork W2594394772 @default.
• W2950133034 hasRelatedWork W2799384978 @default.
• W2950133034 hasRelatedWork W3093750562 @default.
• W2950133034 hasRelatedWork W4300065979 @default.
• W2950133034 hasRelatedWork W4301436834 @default.
• W2950133034 hasVolume "182" @default.
• W2950133034 isParatext "false" @default.
• W2950133034 isRetracted "false" @default.
• W2950133034 magId "2950133034" @default.
• W2950133034 workType "article" @default.